Oncology

Latest News

The new report suggests the C5a-C5aRq axis might be a useful target in combination with existing therapies for cutaneous squamous cell carcinoma. | Image credit: vladimircaribb - stock.adobe.com
C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma

June 7th 2025

The findings are notable in part because therapies have already been approved to target C5aR1 in other diseases.

The study identified several molecular markers related to SCLC prognosis by integrating somatic mutation profiles, mRNA transcriptome data, and clinical information. | Image credit: vitstudio - stock.adobe.com
Novel Biomarkers May Inform Prognosis in SCLC

June 6th 2025

Structured exercise programs should be a part of the standard of care for colon cancer following adjuvant chemotherapy, authors of the COMMANDS study recommended. | Image credit: Drazen - stock.adobe.com
Structured Exercise Program Improves Outcomes, Quality of Life in Colon Cancer

June 6th 2025

young adult cancer | Image credit: Roswell Park Cancer Center
ASCO Sessions Explore Data and Dynamics of Early-Onset Cancer

June 6th 2025

FDA headquarters | Image Credit: - Tada Images- stock.adobe.com
5 Key FDA Approval Dates Mark a Milestone-Filled May

June 6th 2025

Join this expert panel to discuss precision medicine in NSCLC, current immunotherapies, and more.

Watch the series now!

Join a panel of leaders as they discuss treatment for patients diagnosed with metastatic NSCLC without driver mutations

More News

This Week in Managed Care: November 7, 2015
November 7th 2015

This Week in Managed Care: November 7, 2015

This week in managed care Kentucky elected a new governor who could bring big changes to the state's Medicaid program, researchers reported that costs of dementia in the last 5 years of life surpass even cancer, and the latest Hospital Safety Score report was released.
Site Logo
November 6th 2015

Plavix Does Not Increase the Risk of Cancer

Surabhi Dangi-Garimella, PhD
The FDA's meta-analyses, following results of the DAPT trial in 2014, have found no association between treatment with the blood thinner clopidogrel (Plavix) and increased incidence of, or death due to, cancer.
Site Logo
November 6th 2015

5 Things to Know About Value in Healthcare

Surabhi Dangi-Garimella, PhD
From CMS to private health plans, professional healthcare organizations to patients and advocacy groups, the discussion nowadays seems to end up with value.
Linda House on Considering How a Patient's Needs May Change
November 5th 2015

Linda House on Considering How a Patient's Needs May Change

As patients with cancer live longer and the disease becomes a chronic disease for many, it becomes important for providers to understand how the needs of the patient change from being newly diagnosed to active therapy to long-term therapy, explained Linda House, president of the Cancer Support Community.
Site Logo
November 5th 2015

Study Yields Path to Smart Treatment in Prostate Cancer

Surabhi Dangi-Garimella, PhD
A blood test that can detect mutations in the androgen receptor can predict response to abiraterone in prostate cancer.
Site Logo
November 5th 2015

Optimizing Hashtags to Organize Health Information on Twitter

Surabhi Dangi-Garimella, PhD
New research, published in JAMA Oncology, presents evidence of how the use of disease-specific hashtags on Twitter can help those with common interests collectively share information.
Site Logo
November 4th 2015

Prostate Cancer Study Rekindles Price Transparency Debate

Surabhi Dangi-Garimella, PhD
Published in the journal Cancer, the study evaluated the short-term and long-term costs of treating patients with low-risk prostate cancer across the entire care spectrum.
Site Logo
November 4th 2015

Contraceptive Procedure Can Reduce the Risk of Specific Subtypes of Ovarian Cancer

Surabhi Dangi-Garimella, PhD
According to a study published in The International Journal of Cancer, tubal ligation can reduce the risk of serous, endometrioid, and clear cell ovarian carcinoma.
Site Logo
November 4th 2015

Kentucky's New Governor Could Change the Terms of Medicaid Expansion

Mary K. Caffrey
Departing Governor Steve Beshear's full embrace of the Affordable Care Act brought health coverage to 500,000 people in Kentucky, including many who had never had insurance. Preventive services increased by more than 100%.
Site Logo
November 3rd 2015

Antihypertensive Drug Could Be an Inexpensive Anticancer Agent

Surabhi Dangi-Garimella, PhD
A new research study published in the Journal of Dermatology has found that propranolol, a commonly used antihypertensive agent, could substantially reduce proliferation of angiosarcoma.
Site Logo
November 3rd 2015

ASCO Confirms Support for the President's Nominee for FDA Commissioner

AJMC Staff
Fifty organizations, including the American Society of Clinical Oncology, have expressed their confidence in Robert Califf, MD, to lead the FDA.
Site Logo
November 3rd 2015

Impact of ASCO Results Hold: Pembrolizumab Granted Breakthrough in Advanced CRC

Surabhi Dangi-Garimella, PhD
After melanoma and non-small cell lung cancer, the FDA has granted Breakthrough Therapy status to pembrolizumab in advanced colorectal cancer patients with mismatched repair deficiency.
This Week in Managed Care: October 31, 2015
October 31st 2015

This Week in Managed Care: October 31, 2015

This week in managed care, The American Journal of Managed Care celebrated 20 years and presented its first Emerging Leader award, plus confusion reigns after study links processed meats to cancer and death rates on the decline.
Site Logo
October 30th 2015

UnitedHealthcare to Expand Existing Bundled Payment Model in Oncology

Surabhi Dangi-Garimella, PhD
With the expansion, UnitedHealthcare will bring 5 more oncology practices on board to participate in its bundled program, which will grow the program to 650 oncologists across 7 states.
Dr Lee Newcomer on Value Calculators and New Immuno-Oncology Agents
October 30th 2015

Dr Lee Newcomer on Value Calculators and New Immuno-Oncology Agents

Although there have been a number of new value calculators created recently, UnitedHealthcare does not plan to use any just now. Instead, it will continue covering regimens recommended by the National Comprehensive Cancer Network and in a few years the company will use data from its prior authorization tool to analyze performance of regimens, explained Lee Newcomer, MD, MHA, senior vice president, Oncology, Genetics and Women's Health, UnitedHealthcare.
Ted Okon Outlines the Purpose of COA's Payer Exchange Summit
October 30th 2015

Ted Okon Outlines the Purpose of COA's Payer Exchange Summit

The Community Oncology Alliance (COA) created its Payer Exchange Summit to get payers who are thinking about getting involved in oncology payment reform or want to know what to do exposed to successful pilots, explained Ted Okon, MBA, executive director of COA.
Site Logo
October 30th 2015

Dr Julie M. Vose to Discuss Value, Quality, and Cost in AJMC Tweetchat

On November 3, at 11 a.m. EST, the president of the American Society of Clinical Oncology will host a tweetchat with The American Journal of Managed Care. Get a preview of Dr. Julie Vose's speech at Patient-Centered Oncology Care.
Site Logo
October 29th 2015

Challenges With Transforming Into an Oncology Medical Home

Surabhi Dangi-Garimella, PhD
At the Payer Exchange Summit on Oncology Payment Reform, hosted by the Community Oncology Alliance, Daniel McKellar, MD, who chairs the Commission on Cancer, insisted on meaningful feedback from the community to ensure adequate transformation of practices into a medical home.
Site Logo
October 29th 2015

Medicaid Coverage for Smoking Cessation Improves, but Barriers Remain, CDC Finds

Mary K. Caffrey
More states cover all recommended evidence-based treatments, although many require copayments or put annual limits on care.
How Could Genetic Testing Have the Most Impact?
October 29th 2015

How Could Genetic Testing Have the Most Impact?

Role of Genetic versus Genomic Testing in Cancer
October 29th 2015

Role of Genetic versus Genomic Testing in Cancer

Can Genomic Testing Help Offset Cancer Care Costs?
October 29th 2015

Can Genomic Testing Help Offset Cancer Care Costs?

Role of Genetic vs Genomic Testing in Cancer
October 29th 2015

Role of Genetic vs Genomic Testing in Cancer

Challenges With Personalized Medicine
October 29th 2015

Challenges With Personalized Medicine

Thoughts on New Developments in Clinical Cancer Care Management
October 29th 2015

Thoughts on New Developments in Clinical Cancer Care Management

Impact of Personalized Medicine on Specific Tumor Types
October 29th 2015

Impact of Personalized Medicine on Specific Tumor Types

Impact of Personalized Medicine on Treatment Decisions
October 29th 2015

Impact of Personalized Medicine on Treatment Decisions

The Value of Personalized Medicine
October 29th 2015

The Value of Personalized Medicine

Evolution of Personalized Medicine and Positive Outcomes
October 29th 2015

Evolution of Personalized Medicine and Positive Outcomes

Applying Personalized Medicine to Impact Outcomes in Different Cancer Types
October 29th 2015

Applying Personalized Medicine to Impact Outcomes in Different Cancer Types

<1
...
117118119120121122123124125
...
185>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo